CCI-779 and Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney Cancer

Name: CCI-779 and Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney Cancer
License: Public Domain

National Cancer Institute (NCI)

ClinicalTrials.gov · Datasets · License: Public Domain

clear cell renal cell carcinoma, recurrent renal cell cancer, stage iv renal cell cancer

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 411296
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.